Agilent Technologies Introduces Next-Generation Ultraviolet-Visible Diode Array Spectrophotometer
Agilent Technologies Inc. introduced the next generation in ultraviolet-visible (UV-Vis) spectroscopy, the Cary 8454 UV-Visible spectrophotometer.
Building on Agilent’s industry-leading photodiode array (PDA) detector technology, the Cary 8454 UV-Vis includes a new version of UV-Vis ChemStation software that integrates with OpenLAB Enterprise Content Manager (ECM). Together they provide the secure data management needed in pharmaceutical and other highly regulated industries. The system is compact, easy to maintain and can collect a complete spectrum in less than one second.
The Cary 8454 UV-Vis is the successor to Agilent’s 8453 UV-Vis, which has long been the UV-Vis spectrophotometer of choice for laboratories conducting pharmaceutical quality assurance and quality control, and for academic and chemical laboratories conducting time-based kinetics analysis.
“For more than 30 years, laboratories have come to rely on the exceptional quality, reliability and ease-of-use of Agilent’s PDA technology,” said Philip Binns, Agilent vice president for spectroscopy products. “We are happy to introduce this newly enhanced system that meets stringent FDA standards for pharmaceutical manufacturing.”
Transitioning from existing earlier models to the Cary 8454 UV-Vis is seamless and enables uninterrupted continuation of existing standard operating procedures.
The Cary 8454 UV-Vis spectrophotometer, the newest addition to Agilent’s molecular spectroscopy portfolio, incorporates world-class PDA technology for life sciences and chemical analysis applications. It incorporates robust PDA detector technology used in Agilent’s liquid chromatography instruments with pre-aligned light sources for easy maintenance and high levels of reliability required in QA/QC labs. Its compact design and open sampling area improve ergonomics for accessory installation and enable easy, error-free sample preparation and results.
